Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
AbSci revenue
AbSci's revenue is $4.5 million.
What is AbSci's revenue?
- AbSci's revenue growth from 2020 to 2024 is -5.15%.
- AbSci has 99 employees, and the revenue per employee ratio is $45,797.
- AbSci's peak quarterly revenue was $3.4M in 2023(q2).
- AbSci peak revenue was $5.7M in 2022.
- AbSci annual revenue for 2023 was 5.7M, -0.5% growth from 2022.
- AbSci annual revenue for 2024 was 4.5M, -20.71% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
AbSci historical revenue
AbSci's peak revenue was $5.7M in 2022. The peak quarterly revenue was $3.4M in 2023(q2).
AbSci's revenue increased from $4.8m in 2020 to $4.5M currently. That's a -5.15% change in annual revenue.
AbSci annual revenue
AbSci annual revenue over time
| Fiscal year / year | AbSci revenue |
|---|---|
| 2020 | $4.8M |
| 2021 | $4.8M |
| 2022 | $5.7M |
| 2023 | $5.7M |
| 2024 | $4.5M |
Rate AbSci's financial transparency
AbSci annual growth
AbSci saw the greatest revenue growth in 2022, when revenue increased by 20.18%.
AbSci had the lowest revenue growth in 2021, when revenue changed by 0.04%.
AbSci annual growth rate over time
| Year | AbSci growth |
|---|---|
| 2021 | 0%↑ |
| 2022 | 20%↑ |
| 2023 | -1%↓ |
| 2024 | -21%↓ |
AbSci quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
AbSci quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2021 | - | $728,000 | $1.5M | $1.5M |
| 2022 | $819,000 | $1.0M | $2.4M | $1.6M |
| 2023 | $1.3M | $3.4M | $744,000 | $338,000 |
| 2024 | $898,000 | $1.3M | $1.7M | $665,000 |
AbSci jobs nearby
Do you work at AbSci?
Is AbSci transparent about its revenue structure?
AbSci financial information
| Company Type | Public |
| Employees Number | 99 |
| Date Founded | 2011 |
| Headquarters | Vancouver, Washington |
| Number of Locations | 1 |
| Revenue | $4.5M |
| Net Income | -$104,904,000 |
| EBITDA | ($89.1M) (2024) |
| Tax Rate | -0.0% |
| Total Assets | $321,008,000 |
| Ticker | ABSI |
AbSci jobs you might like
AbSci financing
AbSci received early financing of $5.1M on 2016-02-02.
| Series | Round size | Date |
|---|---|---|
| Series A | $5.1M | 02/2016 |
| Series C | $12M | 05/2018 |
| Series D | $10.4M | 01/2019 |
| Debt Financing | $5M | 12/2019 |
| Series D | $10.4M | 01/2020 |
| Series E | $70.0M | 10/2020 |
| Series Unknown | $125M | 03/2021 |
AbSci investors
| Investors | Security type |
|---|---|
| Phoenix Venture Partners LLC | Series A |
| Oregon Venture Fund | Series A |
| R Group | Series A |
| Greenbridge Partners | Series C |
| Phoenix Venture Partners LLC | Series C |
| Washington Research Foundation | Series C |
| Corporation Ventures | Series C |
| Oregon Venture Fund | Series C |
| AGC | Series C |
| Essential Consultants, LLC | Series C |
| JSR Corp | Series D |
| KBI Biopharma Inc | Series D |
| Phoenix Venture Partners LLC | Series D |
| Columbia Ventures Corporation | Series D |
| WRF Capital | Series D |
| KBI Biopharma Inc | Series D |
| Oregon Venture Fund | Series D |
| JSR Life Sciences | Series D |
| Redmile Group | Series E |
| Phoenix Venture Partners LLC | Series E |
| ArrowMark Partners | Series E |
| Casdin Capital | Series E |
| Redmile Group | Series Unknown |
| Helicase Venture | Series Unknown |
| D1 Capital Partners | Series Unknown |
| ArrowMark Partners | Series Unknown |
| Perceptive Advisors | Series Unknown |
| aMoon Fund | Series Unknown |
| Fidelity Management & Research Co LLC | Series Unknown |
| Casdin Capital | Series Unknown |
| Irving Investors | Series Unknown |
AbSci competitors
AbSci's top competitor, Pelican Expression Technology, earned an annual revenue of $39.1M.
AbSci's smallest competitor is CytoLogic with revenue of $250.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Pelican Expression Technology | - | $39.1M | 71 | - |
| LabGenius | - | $1.2M | 51 | - |
| ioGenetics | - | $1.5M | 3 | - |
| ViewPoint Therapeutics | - | $1.5M | 8 | - |
| Obsidian Therapeutics | - | $1.5M | 75 | - |
| CytoLogic | - | $250,000 | 2 | - |
| Vaxart | - | $28.7M | 110 | - |
| Cognition Therapeutics | - | $19.5M | 30 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
AbSci highest paying jobs
Zippia gives an in-depth look into the details of AbSci, including salaries, political affiliations, employee data, and more, in order to inform job seekers about AbSci. The employee data is based on information from people who have self-reported their past or current employments at AbSci. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by AbSci. The data presented on this page does not represent the view of AbSci and its employees or that of Zippia.
AbSci may also be known as or be related to AbSci, AbSci, LLC and Absci.